The Merck Company Foundation has pledged an additional $21 million to support MCAN through 2014; the investment in MCAN for 2010 was $4.4 million. Outcome measures for Phase II of MCAN (2010-2014) are being developed.
- Corporate Responsibility
- Priorities & Performance
- Access to Health
- Research & Development
- Manufacturing & Supply
- Registration
- Commercialization
- Community Investment
- Public/Private Partnerships
- Merck Medical Outreach Program
- Patient Assistance Programs
- Healthcare Capacity Building
- HIV/AIDS
- Vaccines
- Women's Health
- Environmental Sustainability
- Employees
- Ethics & Transparency
- Access to Health
- Public Policy & Advocacy
- Giving at Merck
- Reporting Indices
- KPIs
- Feature Stories
- Take the Survey
